These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4166403)

  • 1. Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum.
    Douglas RG; Rossen RD; Butler WT; Couch RB
    J Immunol; 1967 Aug; 99(2):297-303. PubMed ID: 4166403
    [No Abstract]   [Full Text] [Related]  

  • 2. The sedimentation behavior of rhinovirus neutralizing activity in nasal secretion and serum following the rhinovirus common cold.
    Rossen RD; Douglas G; Cate TR; Couch RB; Butler WT
    J Immunol; 1966 Oct; 97(4):532-8. PubMed ID: 4289223
    [No Abstract]   [Full Text] [Related]  

  • 3. The sedimentation and antigenic properties of proteins in nasal and other external secretions.
    Rossen RD; Butler WT; Vannier WE; Douglas RG; Steinberg AG
    J Immunol; 1966 Dec; 97(6):925-38. PubMed ID: 4163011
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of the neutralizing activity in nasal wash and serum following intranasal vaccinaion with inactivated type 13 rhinovirus.
    Knopf HL; Perkins JC; Bertran DM; Kapikian AZ; Chanock RM
    J Immunol; 1970 Mar; 104(3):566-73. PubMed ID: 4314177
    [No Abstract]   [Full Text] [Related]  

  • 5. Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus.
    Alford RH; Rossen RD; Butler WT; Kasel JA
    J Immunol; 1967 Apr; 98(4):724-31. PubMed ID: 4164554
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness.
    Perkins JC; Tucker DN; Knopf HL; Wenzel RP; Kapikian AZ; Chanock RM
    Am J Epidemiol; 1969 Dec; 90(6):519-26. PubMed ID: 4312066
    [No Abstract]   [Full Text] [Related]  

  • 7. An ELISA for the detection of rhinovirus specific antibody in serum and nasal secretion.
    Barclay WS; Al-Nakib W
    J Virol Methods; 1987 Jan; 15(1):53-64. PubMed ID: 3027117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infection.
    Eggleston PA; Hendley JO; Gwaltney JM
    Acta Otolaryngol Suppl; 1984; 413():25-35. PubMed ID: 6099951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human IgG and IgA diphtheria antitoxins in serum, nasal fluids and saliva.
    Newcomb RW; Ishizaka K; DeVald BL
    J Immunol; 1969 Aug; 103(2):215-24. PubMed ID: 4184822
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental rhinovirus infection in human volunteers exposed to ozone.
    Henderson FW; Dubovi EJ; Harder S; Seal E; Graham D
    Am Rev Respir Dis; 1988 May; 137(5):1124-8. PubMed ID: 2461669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to rhinovirus in human sera. II. Heterotypic responses.
    Fleet WF; Douglas RG; Cate TR; Couch RB
    Proc Soc Exp Biol Med; 1968 Feb; 127(2):503-9. PubMed ID: 4296291
    [No Abstract]   [Full Text] [Related]  

  • 12. [Occurrence of neutralizing antibodies against equine rhinovirus (strain NM 11) in horse stocks in Berlin].
    Teufel P; Keller H
    Berl Munch Tierarztl Wochenschr; 1970 Dec; 83(23):466-7. PubMed ID: 4322035
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunology of the tears.
    Allansmith M
    Int Ophthalmol Clin; 1973; 13(1):47-72. PubMed ID: 4135039
    [No Abstract]   [Full Text] [Related]  

  • 14. The time course of the humoral immune response to rhinovirus infection.
    Barclay WS; al-Nakib W; Higgins PG; Tyrrell DA
    Epidemiol Infect; 1989 Dec; 103(3):659-69. PubMed ID: 2558033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration of gamma-A-globulin in serum, saliva, and nasopharyngeal secretions of infants and children.
    Haworth JC; Dilling L
    J Lab Clin Med; 1966 Jun; 67(6):922-33. PubMed ID: 4161936
    [No Abstract]   [Full Text] [Related]  

  • 16. CHARACTERIZATION OF VIRUS NEUTRALIZING ANTIBODIES IN HUMAN SERUM AND NASAL SECRETIONS.
    BELLANTI JA; ARTENSTEIN MS; BUESCHER EL
    J Immunol; 1965 Mar; 94():344-51. PubMed ID: 14279784
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of an enzyme-linked immunosorbent assay that measures rhinovirus-specific antibodies in human sera and nasal secretions.
    Barclay WS; Callow KA; Sergeant M; al-Nakib W
    J Med Virol; 1988 Aug; 25(4):475-82. PubMed ID: 2844987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contamination of the population with rhinovirus type 1A, 1B and 7].
    Mentel R; Oberender H; Schmidt J
    Z Gesamte Hyg; 1971 Sep; 17(9):676-8. PubMed ID: 4333182
    [No Abstract]   [Full Text] [Related]  

  • 19. Demonstration and characterization of antibody in tears following intranasal vaccination with inactivated type 13 rhinovirus: a preliminary report.
    Knopf HL; Bertran DM; Kapikian AZ
    Invest Ophthalmol; 1970 Oct; 9(10):727-34. PubMed ID: 4320302
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemagglutination-inhibition test in rhinovirus infections of volunteers.
    Reed SE; Hall TS
    Infect Immun; 1973 Jul; 8(1):1-3. PubMed ID: 4352454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.